Academic clinicians with unique skill sets

In 2020, we welcomed our first cohort of MB-PhD students and Clinical Research Training Fellows

Ryan Devlin
Ryan is a first year MB-PhD student in the labs of Dr Ed Roberts (GLA) and Dr Tak Kitamura (EDI). His project focuses on a phenomenon called myeloid skewing where immune cell production shifts towards the bone marrow. He is investigating how this affects the anti-tumour response of the immune system.

 

Tian En Lim
Tian En is a first year MB-PhD student working with Dr Simon Wilkinson (EDI) and Professor Neil Carragher (EDI). His project focuses on identifying drugs that promote the anti-tumour response of the immune system.

Lorna Stillie
Lorna is a first year MB-PhD student under the supervision of Professor Charlie Gourley (EDI) and Professor Gareth Inman (GLA). Her project focuses on the most common form of epithelial ovarian cancer. She is investigating the role of the MAPK pathway – often defect in this pathway can lead to uncontrolled growth and cancer.

Mairi Treanor-Taylor
Mairi is a first year MB-PhD student in the labs of Professor Gareth Inman (GLA) and Professsor Charlie Gourley (EDI). Her project focuses on one of the main types of skin cancer, cutaneous squamous cell carcinoma, aiming to identify drivers and therapeutic vulnerabilities for its metastasis.

Doug is a clinical research fellow in his second year of doctoral training working with Prof Sara Zanivan and Dr Rosalind Glasspool. His project focuses on the metabolic interplay between cancer-associated fibroblasts and tumour cells. Using cutting edge proteomics, he aims to identify vulnerabilities that can be exploited for therapy in ovarian carcinoma metastases.

Michael is a clinical research fellow in his second year of doctoral training under the supervision of Professor Owen Sansom. His project focuses on understanding the response to radiotherapy treatment in rectal cancer. He is investigating the impact radiotherapy has on the tumour microenvironment, in particular the immune system.

Mark is a clinical research fellow in his second year of doctoral training in the labs of Prof Richard Wilson (GLA) and Prof Owen Sansom (GLA). His project aims to improve the outcomes in a subtype of advanced colorectal cancer. Using a suite of preclinical models, he studies the molecular response to novel and combination therapies.